CD112 is an epithelial-to-mesenchymal transition-related and immunological biomarker in pan-cancer
Abstract Background: The nectin adhesion molecule CD112, an important component of tumor progression, belongs to the nectin family. However, a…
Cancer prognosis
Pan-cancer analysis of the disulfidptosis-related gene RPN1 and its potential biological function and prognostic significance in gliomas
Abstract Background: Numerous studies have shown a strong correlation between disulfidptosis and various cancers. However, the expression and function of…
Identification of PANoptosis-related genes as prognostic indicators of thyroid cancer
Abstract Background: Thyroid cancer (THCA) has become a common malignancy in recent years, with the mortality rate steadily increasing. PANoptosis…
APOA1 mRNA and serum APOA1 protein as diagnostic and prognostic biomarkers in gastric cancer
Abstract Background: Gastric cancer (GC) remains a formidable challenge in oncology, ranking as a leading cause of cancer mortality globally.…
NGEF is a potential prognostic biomarker and could serve as an indicator for immunotherapy and chemotherapy in lung adenocarcinoma
Abstract Background: Neuronal guanine nucleotide exchange factor (NGEF) plays a key role in several cancers; however, its role in lung…
A bird’s eye view of the potential role of NFKBIA in pan-cancer
Abstract In the 21st century, cancer remains a serious threat to people’s health and has become a prominent public health…
Pan-Cancer Analysis of ART1 and its Potential Value in Gastric Cancer
Abstract Objective: To comprehensively explore the impact of Mono-ADP-ribosyltransferases-1 expression on both prognosis and the intricate landscape of the tumor…
Association analysis of FXYD5 with prognosis and immunological characteristics across pan-cancer
Abstract Background: The FXYD domain-containing ion transport regulator 5 (FXYD5) gene is a cancer promoter. However, evidence for an association…
The prognostic value and immunological role of MVP in pan-cancer study
Abstract Major Vault Protein (MVP) has emerged as a potential prognostic and immunological biomarker in various cancer types. This pan-cancer…
HLF is a promising prognostic, immunological, and therapeutic biomarker in human tumors
Abstract Despite past research linking HLF mutations to cancer development, no pan-cancer analyses of HLF have been published. As a…